Cyto-Facto is a startup based in Japan.
Cyto-Facto provides contract manufacturing services for cell and gene therapy products, operating facilities and systems designed to meet international standards for clinical and commercial production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.